Impact of 6-OHDA injection and microtrauma in the rat substantia nigra on local brain amyloid beta protein concentrations in the affected area.
- 22 October 2024
- journal article
- Vol. 40 (4) , 485-492
Abstract
Amyloid beta peptides (Aβ) are key indicators of Alzheimer's disease and are also linked to cognitive decline in Parkinson's disease (PD) and other neurodegenerative disorders. This study explored the accumulation of Aβ in a standard 6-Hydroxydopamine (6-OHDA) model of PD. We unilaterally injected 6-OHDA into the substantia nigra of Wistar rats to induce dopaminergic cell degeneration and death, a characteristic of PD. The goal was to detect Aβ protein in tissues and blood vessels showing inflammation or degeneration from the 6-OHDA injection. Our results showed that 6-OHDA injection produced a statistically significant rise in Aβ concentration at the injection site 60 minutes after injection, which was slightly reduced 24 hours post-injection but still significantly higher than in controls. We also tried Gp120 injection in the same zone but it only produced effects comparable to control needle trauma. The presence of Aβ in tissues and blood vessel walls after injection was confirmed through ELISA tests and was supported by immunohistochemical staining of injection areas. We found that the increased Aβ concentration was visible in and around blood vessels and inside blood vessel walls, and also, to a lesser extent in some cells, most probably neurons, in the area. This research highlights the connection between dopaminergic cell poisoning and the accumulation of Aβ, offering insights into the progression of PD to cognitive disorders and dementia.Keywords
This publication has 35 references indexed in Scilit:
- Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted miceExperimental Neurology, 2008
- Striatal β-Amyloid Deposition in Parkinson Disease With DementiaJournal of Neuropathology & Experimental Neurology, 2008
- Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study.2008
- Rodent Aβ Modulates the Solubility and Distribution of Amyloid Deposits in Transgenic MiceJournal of Biological Chemistry, 2007
- Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's diseaseMolecular Neurodegeneration, 2007
- Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic miceNeurobiology of Disease, 2006
- α-Synuclein in Lewy bodiesNature, 1997
- Amyloid β‐peptide and the dementia of Parkinson's dieaseMovement Disorders, 1996
- The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous systemNeuron, 1995
- Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.Proceedings of the National Academy of Sciences, 1993